Cellmid Limited upgraded revenue guidance for the financial year ending 30 June 2015. The company upgraded its revenue guidance to $2 million for the financial year ending 30 June 2015. The improved performance is largely the result of increased sales of the company's consumer health products in Australia and Japan.

The company expected to considerably exceed fiscal year 2015 sales levels during the upcoming fiscal year 2016.